ASCP Corner: Is the Problem of a High Placebo Response Unique to Antidepressant Trials?
J Clin Psychiatry 2008;69:1979-1980
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.
Recent studies questioning the effectiveness of antidepressants
have received considerable attention in the mass media.
These articles report the difficulty in demonstrating superiority
of antidepressants over placebo among antidepressant trials.
Interestingly, placebo response also plays a significant role in
trials of other nonpharmacologic somatic treatments for depression
as well as treatments for many other chronic psychiatric
and nonpsychiatric illnesses; however, this does not seem to
have received similar attention.